SLC1A5 and colorectal carcinoma: Thus, the inhibition of LAT1 and ASCT2 expression levels could represent a promising therapeutic approach for CRC since it would reduce the AA intake, consequently causing mTOR pathway inhibition and compromising cancer cell proliferation.